Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population

American Journal of Hypertension

Volumn 10, Issue 1, 1997, Pages 77-83

  Masuo, Kazuko ^a   Mikami, Hiroshi ^a   Ogihara, Toshio ^a   Tuck, Michael L ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

blood pressure elevation; borderline hypertension; insulin sensitivity; Japanese; normotension; sympathetic nerve activity

Indexed keywords

NORADRENALIN;

ADRENERGIC ACTIVITY; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYMPATHETIC NERVE;

ADULT; BLOOD PRESSURE; HUMANS; HYPERINSULINISM; HYPERTENSION; JAPAN; MALE; SYMPATHETIC NERVOUS SYSTEM;

EID: 0031036701     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(96)00303-2     Document Type: Article

References (35)

1. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med. 317:1987;350-357.
2. Reaven GM, Lithel H, Lansberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 334:1996;374-381.
3. Lucas CP, Estigarribia JA, Darga LL, Reaven GM. Insulin and blood pressure in obesity. Hypertension. 7:1985;702-706.
4. Gudbjornsdottir S, Elam M, Sellgren J, Anderson EA. Insulin increases forearm vascular resistance in obese, insulin-resistant hypertensives. J Hypertens. 14:1996;91-97.
5. Sowers JR. Insulin resistance, hyperinsulinemia, dyslipidemia, hypertension, and accelerated atherosclerosis. J Clin Pharmacol. 32:1992;529-535.
6. Lind L, Berne C, Lithell H. Prevalence of insulin resistance in essential hypertension. J Hypertens. 13:1995;1457-1462.
7. Ferrari P, Weidmann P. Insulin, insulin sensitivity and hypertension. J Hypertens. 8:1990;491-500.
8. Masuo K, Mikami H, Ogihara T, Tuck ML. Does reduced insulin sensitivity and dyslipidemia exist in borderline hypertensive patients? Am J Hypertens. 9:1996;566-569.
9. Esler M, Lambert G, Jennings G. Increased regional sympathetic nervous activity in human hypertension: causes and consequences. J Hypertens. 8:((suppl 7)):1990;S53-S57.
10. Ferrier C, Esler MD, Eisenhofer G, et al. Increased norepinephrine spillover into the jugular veins in essential hypertension. Hypertension. 19:1992;62-69.
11. Masuo K, Ogihara T, Kumahara Y, et al. Increased plasma norepinephrine in young patients with essential hypertension under three sodium intakes. Hypertension. 6:1984;315-321.
12. Flotras JS, Aylward PE, Mark AL, Abboud FM. Adrenaline facilitates neurogenic vasoconstriction in borderline hypertensive subjects. J Hypertens. 8:1990;443-448.
13. Tuck ML. Obesity, the sympathetic nervous system and essential hypertension. Hypertension. 19:((suppl 1)):1992;I-67-I-77.
14. Julius S. Abnormalities of an automatic control in human hypertension. Cardiovasc Drugs Ther. 8:((suppl 1)):1994;11-20.
15. Ward KD, Sparrow D, Landsberg L, et al. Influence of insulin, sympathetic nervous system activity, and obesity on blood pressure: the Normative Aging Study. J Hypertens. 14:1996;301-308.
16. Julius S, Jamerson K. Sympathetics, insulin resistance and coronary risk in hypertension: the "chicken-and-egg" question. J Hypertens. 12:1994;495-502.
17. Anderson EA, Balon TW, Hoffman RP, et al. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension. 19:1992;621-627.
18. Moreau P, Lamarche L, Laflamme AK, et al. Chronic hyperinsulinemia and hypertension: the role of the sympathetic nervous system. J Hypertens. 13:1995;333-340.
19. Townsent R, Yamamoto R, Nickols M, et al. Insulin enhances pressor responses to norepinephrine in rat mesenteric vasculature. Hypertension. 19:((suppl II)):1992;II-105-II-110.
20. Anderson EA, Hoffman RP, Wikstrand J, Anderson OK. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 87:1991;2246-2252.
21. Masuo K, Mikami H, Ogihara T, Tuck M. Differences in insulin and sympathetic responses to glucose ingestion due to family history of hypertension. Am J Hypertens. 9:1996;739-745.
22. Beatty OL, Harper R, Sheridan B, et al. Insulin resistance in offspring of hypertensive parents. Br Med J. 307:1993;92-96.
23. Ferrari P, Weidmann P, Shaw S, et al. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med. 91:1991;589-596.
24. Saad M, Lillioja S, Nyomba B, et al. Racial differences in relation between blood pressure and insulin resistance. N Engl J Med. 324:1991;733-739.
25. Lima JJGD, Dias MM, Benardes-Silva H, Bellotti G. Pressor response to norepinephrine in essential hypertension. A study in families. Hypertension. 15:((suppl I)):1990;I-137-I-139.
26. Munger RG, Prineas RJ, Gomez-Marin O. Persistent elevation of blood pressure among children with a family history of hypertension: the Minneapolis children's blood pressure study. J Hypertens. 6:1988;647-653.
27. Yamatodani A, Wada H. Automated analysis for plasma epinephrine and norepinephrine by liquid chromatography including a sample cleanup procedure. Clin Chem. 27:1981;1983-1987.
28. Mykkanen L, Haffner SM, Ronnemaa T, et al. Relationship of plasma insulin concentration and insulin sensitivity to blood pressure. Is it modified by obesity? J Hypertens. 14:1996;399-405.
29. Nilsson P, Lindholm L, Schersten B. Hyperinsulinemia and other metabolic disturbances in well-controlled hypertensive men and women: an epidemiological study of the Dalby population. J Hypertens. 8:1990;953-959.
30. Lind L, Berne C, Lithell H. Prevalence of insulin resistance in essential hypertension. J Hypertens. 13:1995;1457-1462.
31. Denker PS, Pollock VE. Fasting serum insulin levels in essential hypertension. Arch Intern Med. 152:1992;1649-1651.
32. Esler M, Jennings G, Lambert G. Noradrenaline release and the pathophysiology of primary human hypertension. Am J Hypertens. 2:((suppl)):1989;140S-146S.
33. Goldstein DS. Plasma norepinephrine in essential hypertension. A study of the studies. Hypertension. 3:1981;48-52.
34. Masuo K, Ogihara T, Kumahara Y, et al. Increased plasma norepinephrine in young patients with essential hypertension under three sodium intakes. Hypertension. 6:1984;315-321.
35. Julius S, Pascual A, Reilly K, London R. Abnormalities of plasma volume in borderline hypertension. Arch Intern Med. 127:1971;116-119.